270 related articles for article (PubMed ID: 35570493)
1. Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Asaoka D; Xiao J; Takeda T; Yanagisawa N; Yamazaki T; Matsubara Y; Sugiyama H; Endo N; Higa M; Kasanuki K; Ichimiya Y; Koido S; Ohno K; Bernier F; Katsumata N; Nagahara A; Arai H; Ohkusa T; Sato N
J Alzheimers Dis; 2022; 88(1):75-95. PubMed ID: 35570493
[TBL] [Abstract][Full Text] [Related]
2. Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.
Xiao J; Katsumata N; Bernier F; Ohno K; Yamauchi Y; Odamaki T; Yoshikawa K; Ito K; Kaneko T
J Alzheimers Dis; 2020; 77(1):139-147. PubMed ID: 32623402
[TBL] [Abstract][Full Text] [Related]
3. Effects of
Kobayashi Y; Kuhara T; Oki M; Xiao JZ
Benef Microbes; 2019 May; 10(5):511-520. PubMed ID: 31090457
[TBL] [Abstract][Full Text] [Related]
4. Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study.
Kobayashi Y; Kinoshita T; Matsumoto A; Yoshino K; Saito I; Xiao JZ
J Prev Alzheimers Dis; 2019; 6(1):70-75. PubMed ID: 30569089
[TBL] [Abstract][Full Text] [Related]
5. Association of Plasma Hemoglobin A1c with Improvement of Cognitive Functions by Probiotic Bifidobacterium breve Supplementation in Healthy Adults with Mild Cognitive Impairment.
Bernier F; Ohno K; Katsumata N; Shimizu T; Xiao J
J Alzheimers Dis; 2021; 81(2):493-497. PubMed ID: 33814441
[TBL] [Abstract][Full Text] [Related]
6. Probiotic
Abdelhamid M; Zhou C; Jung CG; Michikawa M
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745273
[TBL] [Abstract][Full Text] [Related]
7. Probiotic
Shi S; Zhang Q; Sang Y; Ge S; Wang Q; Wang R; He J
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615708
[TBL] [Abstract][Full Text] [Related]
8. Effects of
Sato S; Arai S; Kato K; Yoshida K; Iwabuchi N; Sagami T; Tanaka M
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542727
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Bifidobacterium breve Prevents Memory Impairment Through the Reduction of Both Amyloid-β Production and Microglia Activation in APP Knock-In Mouse.
Abdelhamid M; Zhou C; Ohno K; Kuhara T; Taslima F; Abdullah M; Jung CG; Michikawa M
J Alzheimers Dis; 2022; 85(4):1555-1571. PubMed ID: 34958017
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
Costeloe K; Bowler U; Brocklehurst P; Hardy P; Heal P; Juszczak E; King A; Panton N; Stacey F; Whiley A; Wilks M; Millar MR
Health Technol Assess; 2016 Aug; 20(66):1-194. PubMed ID: 27594381
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease.
Kobayashi Y; Sugahara H; Shimada K; Mitsuyama E; Kuhara T; Yasuoka A; Kondo T; Abe K; Xiao JZ
Sci Rep; 2017 Oct; 7(1):13510. PubMed ID: 29044140
[TBL] [Abstract][Full Text] [Related]
12. Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
Kim CS; Cha L; Sim M; Jung S; Chun WY; Baik HW; Shin DM
J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(1):32-40. PubMed ID: 32300799
[TBL] [Abstract][Full Text] [Related]
13. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
[TBL] [Abstract][Full Text] [Related]
14. Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice.
Ohno K; Abdelhamid M; Zhou C; Jung CG; Michikawa M
J Alzheimers Dis; 2022; 89(4):1413-1425. PubMed ID: 36057824
[TBL] [Abstract][Full Text] [Related]
15. Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial.
Solito A; Bozzi Cionci N; Calgaro M; Caputo M; Vannini L; Hasballa I; Archero F; Giglione E; Ricotti R; Walker GE; Petri A; Agosti E; Bellomo G; Aimaretti G; Bona G; Bellone S; Amoruso A; Pane M; Di Gioia D; Vitulo N; Prodam F
Clin Nutr; 2021 Jul; 40(7):4585-4594. PubMed ID: 34229263
[TBL] [Abstract][Full Text] [Related]
16. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
[TBL] [Abstract][Full Text] [Related]
17. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
Patole S; Keil AD; Chang A; Nathan E; Doherty D; Simmer K; Esvaran M; Conway P
PLoS One; 2014; 9(3):e89511. PubMed ID: 24594833
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects.
Inoue T; Kobayashi Y; Mori N; Sakagawa M; Xiao JZ; Moritani T; Sakane N; Nagai N
Benef Microbes; 2018 Dec; 9(6):843-853. PubMed ID: 30198326
[TBL] [Abstract][Full Text] [Related]
19. Potential Therapeutic Effects of
Abdelhamid M; Jung CG; Zhou C; Inoue R; Chen Y; Sento Y; Hida H; Michikawa M
Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398861
[TBL] [Abstract][Full Text] [Related]
20. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
